Skip to main content

Table 2 Patient’s pharmacogenetic test results

From: Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report

Gene

Genotype

Predicted Phenotype

CYP2C19

*1/*2

Intermediate Metabolizer

CYP2D6

*1/*2

Extensive (Normal) Metabolizer

CYP3A4/CYP3A5

*1/*1; *1/*1

Extensive (Normal) Metabolizer

UGT2B15

*1/*1

Extensive (Normal) Metabolizer

DRD2

INS/DEL

Reduced Responder

HTR2C

C/C

Normal Expressor

MTHFR

C/C (C677T); A/A (A1298C)

Normal Activity

  1. CYP cytochromes P450, UGT uridine 5′-diphospho-glucuronosyltransferase, DRD2 dopamine receptor D2 gene, HTR2C 5-hydroxytryptamine receptor 2C gene, MTHFR methylene tetrahydrofolate reductase gene